Barclays on Wednesday downgraded medical technology company Smith & Nephew (SN.L) to underweight from equal weight and lowered its price target to 10.50 pounds sterling from 12.90 pounds.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)